Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel therapies in AML: reason for hope or just hype?

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting - 1 Jan 2014

Larkin Karilyn, Blum William

Abstract excerpt

We have entered the genomic sequencing era in the treatment of acute myeloid leukemia (AML); our patients increasingly and justifiably demand personalized treatment based on aberrations of their own leukemia. Except in rare cases we are not yet able to provide truly personalized therapy, so the question of "hope or hype?" posed by the American Society for Clinical Oncology (ASCO) for this educational topic is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Bone Marrow
Share to Cancer Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Leukemia, Myeloid, Acute

Share to Molecular Targeted Therapy

Share to Proto-Oncogene Proteins c-kit

Share to Stem Cell Transplantation

Source

Identifiers

PMID: 24857123
DOI: 10.14694/EdBook_AM.2014.34.e341

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel therapies in AML: reason for hope or just hype?PMID 24857123Read ↗

Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting ChallengesSemantic proximity Read ↗

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid LeukemiaSemantic proximity Read ↗

New drugs for acute myeloid leukemia inspired by genomics and when to use themSemantic proximity Read ↗

Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary Review.Semantic proximity Read ↗

Emerging therapies for acute myeloid leukemia: translating biology into the clinic.Semantic proximity Read ↗

The Black Hole: CAR T Cell Therapy in AMLSemantic proximity Read ↗

The Black Hole: CAR T cell Therapy in AMLSemantic proximity Read ↗

An overview of novel therapies in advanced clinical testing for acute myeloid leukemia.Semantic proximity Read ↗

An Overview of Targeted Therapies in Acute Myeloid LeukemiaSemantic proximity Read ↗

Cutting Edge Molecular Therapy for Acute Myeloid Leukemia.Semantic proximity Read ↗

New strategies to treat AML: novel insights into AML survival pathways and combination therapiesSemantic proximity Read ↗

Recent advances in the understanding and treatment of acute myeloid leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.